Can Trulicity (dulaglutide) be used for preventing heart and kidney complications in diabetics without existing heart disease?

### Trulicity (Dulaglutide) and Its Benefits for Diabetics Trulicity (dulaglutide) is a medication commonly prescribed for people with type 2 diabetes, especially those who also have heart disease. Recent studies have shown that Trulicity not only helps manage blood sugar levels but also reduces the risk of heart attacks, strokes, and kidney disease. This is particularly significant because people with type 2 diabetes are at a higher risk of developing these complications. In a large clinical trial called REWIND, involving 9,900 participants from 24 countries, researchers found that Trulicity lowered the risk of heart attacks and strokes by 12% and reduced the development of kidney disease by 15%. The study included people with type 2 diabetes who had risk factors for cardiovascular disease but had not yet developed it. This makes the findings applicable to a broad range of people with diabetes, not just those with existing heart conditions. Trulicity is administered as a once-weekly injection and works by helping the pancreas release the right amount of insulin when blood sugar levels are high. It may also help reduce appetite and aid in weight loss. The most common side effects are gastrointestinal issues like constipation or diarrhea. The study's findings suggest that Trulicity could be beneficial for a wider range of people with type 2 diabetes, including those who have not yet developed cardiovascular disease. This opens up new possibilities for using the medication as a preventive measure against heart and kidney complications in diabetics. If you have type 2 diabetes, it's worth discussing with your doctor whether Trulicity could be a good option for you, even if you don't have existing heart disease. The medication has shown promising results in reducing the risk of serious complications and could be an important part of your diabetes management plan.